Edition:
United Kingdom

Vertex Pharmaceuticals Inc (VRTX.OQ)

VRTX.OQ on NASDAQ Stock Exchange Global Select Market

173.78USD
10 Dec 2018
Change (% chg)

-- (--)
Prev Close
$173.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
488,018
52-wk High
$194.85
52-wk Low
$139.80

Chart for

About

Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. The... (more)

Overall

Beta: 1.67
Market Cap(Mil.): $39,103.64
Shares Outstanding(Mil.): 252.12
Dividend: --
Yield (%): --

Financials

  VRTX.OQ Industry Sector
P/E (TTM): 150.12 92.25 33.63
EPS (TTM): 1.03 -- --
ROI: 12.80 0.28 15.02
ROE: 19.56 0.94 16.60

Vertex posts positive data from cystic fibrosis triple combo trials

Vertex Pharmaceuticals Inc said on Tuesday that its triple combination therapy showed significant improvement in lung function in patients with cystic fibrosis (CF) in two late-stage clinical studies, sending its shares up 5 percent.

27 Nov 2018

REFILE-Vertex posts positive data from cystic fibrosis triple combo trials

Nov 27 Vertex Pharmaceuticals Inc said on Tuesday that its triple combination therapy showed significant improvement in lung function in patients with cystic fibrosis (CF) in two late-stage clinical studies, sending its shares up 5 percent.

27 Nov 2018

Vertex cystic fibrosis drug gets expanded approval for use in infants

U.S. health regulators have expanded the use of one of Vertex Pharmaceuticals Inc's cystic fibrosis drugs to include patients aged between 12 months and 24 months.

15 Aug 2018

Vertex cystic fibrosis drug gets expanded approval for use in infants

Aug 15 U.S. health regulators have expanded the use of one of Vertex Pharmaceuticals Inc's cystic fibrosis drugs to include patients aged between 12 months and 24 months.

15 Aug 2018

Earnings vs. Estimates